Planta Med 2005; 71(6): 561-563
DOI: 10.1055/s-2005-864159
Letter
© Georg Thieme Verlag KG Stuttgart · New York

A Biflavonoid from Luxemburgia nobilis as inhibitor of DNA Topoisomerases

Marcia C. Oliveira1 , Mario G. de Carvalho1 , Noema F. Grynberg1 , Paulo S. Brioso2
  • 1Departamento de Química, Instituto de Ciências Exatas, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ, Brazil
  • 2Departamento de Entomologia e Fitopatologia, Instituto de Biologia, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ, Brazil
Further Information

Publication History

Received: August 9, 2004

Accepted: February 13, 2005

Publication Date:
21 June 2005 (online)

Abstract

The biflavonoid 2′′,3′′-diidroochnaflavone (1), isolated from the leaves of Luxemburgia nobilis, was cytotoxic to murine Ehrlich carcinoma (IC50 = 17.2 μM) and human leukemia K562 cells (IC50 = 89.0 μM) in a concentration-dependent manner in 45 h cell culture. The acetyl (1a) and methyl (1b) derivatives of 1 were not cytotoxic to these tumour cells at 67.0 and 82.0 μM concentrations, respectively. Biflavonoid 1 as well 1a inhibit the activity of human DNA topoisomerases I and II-α as observed in relaxation and decatenation assays. In addition, we show that 1 is a DNA interacting agent, which causes DNA unwinding in an assay with topoisomerase I. Also, spectrophotometric titration of 1 with DNA resulted in a pronounced hypochromic effect.

References

  • 1 Oliveira M CC, Carvalho M G, Silva C J, Werle A. A New biflavonoid and other constituents from Luxembergia nobilis (EICHL).  J Bras Chem Soc. 2002;  13 119-23
  • 2 Grynberg N F, Carvalho M G, Velandia J R, Oliveira M C, Moreira I C, Braz-Filho R, Echevarria A. DNA topoisomerase inhibitors: biflavonoids from Ouratea species.  Braz J Med Biol Res. 2002;  35 819-22
  • 3 Kellner U, Rudolph P, Parwaresch R. Human DNA-topoisomerases - diagnostic and therapeutic implications for cancer.  Onkologie. 2000;  23 424-30
  • 4 Hall G D, Perren T J. The role of topoisomerase inhibition in gynaecological oncology.  Rev Gynaecol Practice. 2002;  2 29-34
  • 5 Middleton E J r, Kandaswami C, Theoharides C T. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer.  Pharmacol Rev. 2000;  32 673-751
  • 6 Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, Andersen A, Jakob F, Köhrle J. Selected novel flavones inhibit the DNA binding on the DNA religation of eukaryotic topoisomerase I.  J Biol Chem. 1996;  271 2262-70
  • 7 Yamashita Y, Kawada S -Z, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol.  Biochem Pharmacol. 1990;  39 737-44
  • 8 Quideau S, Jourdes M, Saucier C, Glories Y, Pardon P, Baudry C. DNA topoisomerase Inhibitor Acutissimin A and other flavano-ellagitannins in red wine.  Angew Chem Int Ed. 2003;  42 6012-4
  • 9 Chowdhury A R, Sharma S, Mandal S, Goswami A, Mukhopadhyay S. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I.  Biochem J. 2002;  366 653-61
  • 10 Pommier Y, Covey J M, Kerrigan D, Markovits J, Pham R. DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators.  Nucl Acid Res. 1987;  15 6713-31
  • 11 Bigland C, Burgess T D, Burton J H. Guide to the care and use of experimental animals. Canada; Canadian Council on Animal Care 1980
  • 12 Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.  J Immunol. 1983;  65 55-63
  • 13 Nandi R, Maiti M. Binding of sanguinarine to deoxyribonucleic acids of differing base composition.  Biochem Pharmacol. 1985;  34 321-4

Marcia C. Oliveira

Departamento de Química, Instituto de Ciências Exatas

Universidade Federal Rural do Rio de Janeiro

23851-970 Seropédica

Rio de Janeiro

Brazil

Fax: +55-21-2682-1872

Email: mccdeo@ibest.com.br

Email: fring.trp@terra.com.br

    >